1) ovarian malignant clear cell carcinoma
卵巢恶性透明细胞癌
2) Ovarian clear cell carcinoma
卵巢透明细胞癌
1.
Ovarian clear cell carcinoma is classified into epithelial tumor.
卵巢透明细胞癌属上皮性肿瘤，因其对传统化疗药物不敏感，即使早期化疗后也常复发，故预后较差。
3) ovarian clear cell adenocarcinoma
卵巢透明细胞癌
1.
Purpose To assess 17β estradiol(E_2) s effect on cell proliferation,cell invasiveness and MTA3,Snail,MMP-2 expression of ovarian clear cell adenocarcinoma cell line ES-2,and to further investigate its mechanisms.
目的研究雌激素对体外培养的卵巢透明细胞癌细胞系ES2增殖、侵袭力的影响和对MTA3、Snail、基质金属蛋白酶2(MMP2)表达的调节作用,以探讨雌激素作用对ES2细胞系的影响。
2.
ER, PR, nm23-Hl, E-cadherin, AKT and pAKT expressions were measured by using of immunohistochemical staining in ovarian clear cell adenocarcinoma, ovarian serous adenocarcinoma, ovarian borderline and benign serous cystadenoma paraffin-embedded specimen.
卵巢透明细胞癌和卵巢浆液性腺癌为恶性程度较高、易转移、复发率高、预后差的两种组织学类型。
4) mesonephroid carcinoma of ovary
卵巢透明细胞癌;卵巢中肾样癌
5) ovarian cancer
卵巢癌细胞
1.
Aim: To identify the difference between transfected human ovarian cancer cells with HSV tk gene under the control of hTERT promoter and non transfected cells.
目的 :观察转染有人端粒酶逆转录酶基因 (humantelomerasereversetranscriptase,hTERT)启动子调控的单纯疱疹病毒Ⅰ型胸苷激酶 (herpessimplexvirusthymidinekinase ,HSV tk)基因的人卵巢癌细胞的部分生物学特性。
6) ovarian cancer cells
卵巢癌细胞
1.
In an attempt to provide a basis for further investigating the mechanism of chemotherapy resistance caused by IL-6 and IL-8 in ovarian cancer cells.
目的分析比较4种常见的人上皮性卵巢癌细胞系IL-6、IL-8分泌与其化疗敏感性及部分耐药相关基因和凋亡抑制基因表达的关系,为今后研究IL-6、IL-8诱导卵巢癌细胞对化疗药物产生耐药的机制奠定基础。
补充资料：卵巢恶性肿瘤细胞减灭术
卵巢恶性肿瘤细胞减灭术
指在手术治疗卵巢癌时，尽可能切除肿瘤组织，使最大残留病灶直径不超过2cm，以利术后采用化疗达到长期缓解甚至根治的目的。手术范围包括全子宫、双附件、阑尾、大网膜及其他可切除的转移病灶，如欲达到成功的肿瘤减灭术时，可包括膀胱和肠道部分切除术。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条